文献速递产科母胎医学

胎儿生长下降幅度而非下降速率是足月婴儿围产期死亡的更强危险因素

The magnitude rather than the rate of decline in fetal growth is a stronger risk factor for perinatal mortality in term infants.
PubMed 文献 · Am J Obstet Gynecol MFM · 2022-10-21

这项在澳大利亚布里斯班Mater Mother's Hospital开展的队列研究纳入15,861例妊娠,分析两次超声间胎儿生长下降幅度与死产、围产期死亡及不良新生儿结局的关系。结果显示,胎儿生长每下降1个百分位,死产和围产期死亡风险分别增加2.6%和2.8%;仅当下降≥50个百分位时,死产和围产期死亡的比值比才显著升高,且与出生体重无关。生长下降速率与主要结局均无显著关联。

要点

  • 胎儿生长每下降1个百分位,死产风险增加2.6%,围产期死亡风险增加2.8%。
  • 仅当生长下降≥50个百分位时,死产和围产期死亡风险才显著升高,且与出生体重无关。
  • 生长下降速率与死产、围产期死亡均无显著关联。

核心结论

  • 研究结果支持将胎儿生长下降≥50个百分位作为识别晚发型胎儿生长受限风险婴儿的标准,该界值也可识别围产期死亡高风险胎儿,且与出生体重和生长下降速率无关。

研究设计与样本

  • 在澳大利亚布里斯班Mater Mother's Hospital开展的队列研究,纳入15,861例妊娠。
  • 胎儿生长下降幅度按孕18周后两次超声之间估测胎儿体重或腹围百分位的下降计算。
  • 分析时将生长下降作为连续变量,若显著则进一步评估下降速率及不同下降幅度,参照组为两次超声间生长变化±10个百分位。
  • 生长下降分为3类:>10至<25个百分位、≤25至<50个百分位、≥50个百分位。
  • 采用逻辑回归分析关联;主要结局为死产和围产期死亡(死产与新生儿死亡的复合结局)。

主要发现

  • 胎儿生长每下降1个百分位,死产风险增加2.6%(0.4%-4.6%),围产期死亡风险增加2.8%(1.0%-4.5%)。
  • 与参照组相比,仅当生长下降≥50个百分位时,死产(校正比值比3.68(1.32-10.24))和围产期死亡(校正比值比4.44(1.82-10.84))的比值比显著升高,且与出生体重无关。
  • 主要结局均与生长下降速率无显著关联。
  • 每下降1个百分位,小于胎龄儿(出生体重低于同孕龄第10百分位)风险增加2.4%(2.2%-2.7%)。
  • 胎儿生长下降与因胎儿状态不可靠行急诊剖宫产或严重新生儿疾病均无关联。

关键数值与推荐

  • 当前德尔菲共识标准将胎儿生长下降>50个百分位纳入晚发型胎儿生长受限的诊断,但支持该标准的证据有限。
  • 本研究中生长下降≥50个百分位与死产校正比值比3.68(1.32-10.24)、围产期死亡校正比值比4.44(1.82-10.84)相关。

临床怎么用

  • 作者认为,研究结果可能指导产科实践,提示临床医生应将胎儿生长下降幅度纳入产前咨询和分娩时机决策。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prenatal diagnosis of an infant suspected of having fetal growth restriction is important because of its strong association with perinatal mortality and morbidity. The current Delphi consensus criteria include a decline of >50th percentiles in fetal growth when diagnosing late fetal growth restriction; however, the evidence underpinning this criterion is limited. OBJECTIVE: This study aimed to analyze the relationships among the magnitude of decline in fetal growth and stillbirth, perinatal mortality, and adverse neonatal outcomes. STUDY DESIGN: This cohort study of 15,861 pregnancies was conducted at the Mater Mother's Hospital in Brisbane, Australia. The decline in fetal growth was calculated as a drop in either estimated fetal weight or abdominal circumference percentiles between 2 ultrasound scans performed after 18 weeks of gestation. Relationships between declining fetal growth and the outcomes were, firstly, analyzed as a continuous variable and, if significant, further assessed with the rate of decline and different magnitudes of decline, compared to the referent category (change in growth of ±10 percentiles between scans). The 3 categories of growth decline were >10th to <25th percentiles, ≤25th to <50th percentiles, and ≥50th percentiles. Associations were analyzed by logistic regressions. The primary study outcomes were stillbirth and perinatal mortality (composite of stillbirth and neonatal death). The secondary outcomes were birth of a small-for-gestational-age infant (birthweight of <10th percentile for gestation), emergency cesarean delivery for nonreassuring fetal status, and composite severe neonatal morbidity. RESULTS: The risks of stillbirth and perinatal mortality increased significantly by 2.6% (0.4%-4.6%) and 2.8% (1.0%-4.5%), respectively, per 1 percentile decline in fetal growth. In addition, the odds of stillbirth (adjusted odds ratio, 3.68 (1.32-10.24) and perinatal mortality (4.44) (1.82-10.84)) compared to the referent group were significantly increased only when the decline was ≥50th percentiles, regardless of birthweight. Furthermore, none of the primary outcomes were significantly associated with the rate of growth decline. The risk of a small-for-gestational-age infant increased by 2.4% (2.2%-2.7%) for every percentile decline. Conversely, reduced fetal growth was not associated with emergency cesarean delivery for nonreassuring fetal status or severe neonatal morbidity. CONCLUSION: Our results supported the use of a ≥50th percentile decline in fetal growth as a criterion for identifying infants at risk of late fetal growth restriction. This cutoff also identified fetuses at high risk of perinatal mortality, regardless of birthweight and rate of growth decline. Our findings may guide obstetrical practice by alerting clinicians to the importance of incorporating the magnitude of fetal growth decline into antenatal counseling and decisions regarding the timing of birth.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Larsen ML, Schreiber V, Krebs L, et al. The magnitude rather than the rate of decline in fetal growth is a stronger risk factor for perinatal mortality in term infants. Am J Obstet Gynecol MFM. 2022. PMID: 36273814. doi:10.1016/j.ajogmf.2022.100780

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。